Inversiones en Start-Ups en el mes de marzo

, ,
Integral service around a transaction
BY : Diego Gutiérrez28/04/2020

A pesar de la crisis del coronavirus, marzo ha sido un buen mes para las inversiones en Start-ups españolas, ya que se cerró el mes con un importe total invertido en Start-ups, parecido al de marzo del año pasado (11,7 millones de euros en marzo del 2020 frente a los 11,3 millones en marzo del 2019).

Se han producido un total de 19 operaciones públicas, todas ellas en fases iniciales e inferiores a 1,5 millones de euros por operación. Además, siete de ellas se han producido a través de las principales plataformas de equity crowdfunding de España.

Sin embargo, en este post vamos a analizar dos de las start-ups que han captado fondos este mes de marzo y que ambas se dedican al desarrollo de tecnologías médicas. Estas dos empresas son Aortyx y Qrem.

AORTYX

Aortyx es una spin-off de IQS que desarrolla un dispositivo endovascular mínimamente invasivo para reducir la tasa de mortalidad en disecciones aórticas. La compañía ha arrancado 2020 con el cierre de una ronda de inversión seed por valor de 650.000 euros. La operación ha estado liderada por Genesis Ventures, que ha invertido junto con los otros 71 inversores con los que cuenta en estos momentos Aortyx.

Con la financiación obtenida, la compañía ha iniciado ya las pruebas en animales y comenzará la industrialización de su producto con el objetivo de comercializarlo en 2024. el Dr. Jordi Martorell, CEO y cofundador de Aortyx, ha afirmado que “Esta inversión nos permitirá continuar cumpliendo los tiempos previstos y mantener nuestro objetivo de lanzar el mejor producto posible al mercado».

QREM

Qrem, con sede en Barcelona, está especializada en el desarrollo y comercialización de tecnologías médicas Lab-in-a-Box para realizar tratamientos de medicina regenerativa autóloga junto al paciente en la consulta médica, que permitan ofrecer estas terapias al mayor número de personas posible de una forma efectiva, sencilla y económica.

La start-up ha comprometido una ampliación de capital de un millón de euros liderada por Inveready y compartido con varios business angels. Qrem lanzó su primer producto, Q-Cytokine, en 2019 y la financiación recibida permitirá reforzar la validación clínica de la terapia, así como incrementar el equipo comercial para escalar las ventas. Como ha indicado Josep M. Escuer, CEO de Qrem, “la inversión nos permite cerrar una etapa de startup para iniciar otra totalmente nueva de empresa comercial que se marca como objetivo llegar a su punto de equilibrio en el mínimo tiempo posible".

The M&A Professionals

Meet our services

MEET
OUR
metodologY

Do you want to be up to date?

SUSCRIBE OUR NEWSLETTER

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
"Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
closearrow-circle-o-downchevron-downcrossmenu